A4642 In111 satumomab
A-Codes
Also known as: OncoScint, In-111 satumomab, tumor imaging agent
Indium-111 labeled satumomab (OncoScint), a radiolabeled monoclonal antibody used for imaging colorectal and ovarian cancer. Binds to tumor-associated glycoprotein 72 (TAG-72).
Clinical Context
Used in nuclear medicine imaging to detect colorectal and ovarian cancer metastases. Injected intravenously and imaged 48-72 hours later. Helps identify occult malignancy.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.